GlassScriptPhysician profile
Diem Q Pham
NPI 1255421335
$10,097.46
in general payments reported to CMS, 2019-2025
36 companies · $2,532 in 2025
The $2,532 reported for 2025 was more than what 81% of Procedural Dermatology providers received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $820 · 2020: $508 · 2021: $729 · 2022: $1,452 · 2023: $2,453 · 2024: $1,605 · 2025: $2,532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,323 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,322.51 |
| Education | $266.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $2,424.88 | 2019-2025 | Adbry, Anzupgo |
| Incyte Corporation | $1,196.79 | 2021-2025 | Opzelura |
| Genzyme Corporation | $923.29 | 2021-2025 | |
| Abbvie INC. | $879.81 | 2021-2025 | |
| Pfizer INC. | $772.08 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $432.60 | 2022-2025 | Dupixent, Libtayo |
| Janssen Biotech, INC. | $423.16 | 2022-2025 | Tremfya, Simponi, Simponi Aria |
| Mayne Pharma Commercial LLC | $393.98 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $388.63 | 2019-2025 | |
| Amgen INC. | $309.98 | 2020-2025 | Otezla, Otezla |
| Dermavant Sciences, INC. | $247.55 | 2023-2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $228.53 | 2023-2025 | Zoryve |
| Ucb, INC. | $214.03 | 2024-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $202.51 | 2023-2024 | Sotyktu |
| Sun Pharmaceutical Industries INC. | $187.53 | 2021-2025 | Winlevi |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $105.04 | 2020-2022 | |
| Krystal Biotech INC | $98.12 | 2023-2024 | Vyjuvek |
| Organon LLC | $85.66 | 2025 | Vtama |
| Vyne Pharmaceuticals INC. | $64.36 | 2020-2021 | |
| Microtransponder, INC. | $56.95 | 2025 | |
| Galderma Laboratories, L.P. | $56.79 | 2024-2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $49.09 | 2019 | |
| Epi Health, LLC | $42.54 | 2020 | |
| Octapharma USA, INC. | $42.29 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.89 | 2023-2024 | Spevigo |
| Sebela Pharmaceuticals INC. | $33.60 | 2019-2020 | |
| Prugen, INC. Pharmaceuticals | $27.92 | 2019 | |
| Lilly USA, LLC | $24.30 | 2022 | |
| Dermira, INC. | $23.89 | 2021 | |
| Abbott Laboratories | $21.69 | 2019 | |
| Biofrontera INC. | $20.96 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Helsinn Therapeutics (U.S.), INC. | $19.31 | 2021 | |
| Genentech USA, INC. | $19.30 | 2019 | |
| Celgene Corporation | $16.80 | 2019 | |
| Nabriva Therapeutics, Plc | $12.80 | 2022 | |
| Merck Sharp & Dohme LLC | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diem Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.